Adverse events220

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 220

Type	Event	Organ system	Group	Affected	At risk	Events
other	Platelet Count Decreased	Investigations	EndoTAG-1 and Gemcitabine	41	102	200
other	Platelet Count Decreased	Investigations	Gemcitabine Monotherapy	42	102	193
other	Neutrophil Count Decreased	Investigations	EndoTAG-1 and Gemcitabine	18	102	83
other	Neutrophil Count Decreased	Investigations	Gemcitabine Monotherapy	21	102	83
other	White Blood Cell Count Decreased	Investigations	EndoTAG-1 and Gemcitabine	18	102	58
other	White Blood Cell Count Decreased	Investigations	Gemcitabine Monotherapy	17	102	71
other	Alanine Aminotransferase Increased	Investigations	EndoTAG-1 and Gemcitabine	17	102	43
other	Alanine Aminotransferase Increased	Investigations	Gemcitabine Monotherapy	17	102	31
other	Aspartate Aminotransferase Increased	Investigations	EndoTAG-1 and Gemcitabine	14	102	30
other	Aspartate Aminotransferase Increased	Investigations	Gemcitabine Monotherapy	17	102	29
other	Gamma-Glutamyltransferase Increased	Investigations	EndoTAG-1 and Gemcitabine	11	102	19
other	Gamma-Glutamyltransferase Increased	Investigations	Gemcitabine Monotherapy	11	102	14
other	Blood Alkaline Phosphatase Increased	Investigations	EndoTAG-1 and Gemcitabine	15	102	32
other	Blood Alkaline Phosphatase Increased	Investigations	Gemcitabine Monotherapy	5	102	9
other	Weight Decreased	Investigations	EndoTAG-1 and Gemcitabine	13	102	19
other	Weight Decreased	Investigations	Gemcitabine Monotherapy	4	102	6
other	Lymphocyte Count Decreased	Investigations	EndoTAG-1 and Gemcitabine	8	102	39
other	Lymphocyte Count Decreased	Investigations	Gemcitabine Monotherapy	7	102	15
other	Epistaxis	Respiratory, thoracic and mediastinal disorders	EndoTAG-1 and Gemcitabine	9	102	14
other	Epistaxis	Respiratory, thoracic and mediastinal disorders	Gemcitabine Monotherapy	2	102	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03126435/events

API reference For AI assistants

Adverse events220

Sources 3

Read this list from software.